In addition, DENV/ZIKV cross-reactive CD8+ T cells played an important role in protecting against ZIKV in peptide vaccination and sequential DENV-ZIKV infection settings in various mice, including HLA transgenic and pregnant animals [24–26]. Here, CD8A is linked to Zika virus infectious disease.